News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
326,323 Results
Type
Article (19517)
Company Profile (139)
Press Release (306667)
Section
Business (105133)
Career Advice (863)
Deals (18485)
Drug Delivery (89)
Drug Development (50601)
Employer Resources (79)
FDA (7628)
Job Trends (7709)
News (185406)
Policy (17284)
Tag
Academia (726)
Alliances (27656)
Alzheimer's disease (553)
Approvals (7591)
Artificial intelligence (75)
Bankruptcy (170)
Best Places to Work (5461)
Biosimilars (66)
Biotechnology (61)
Cancer (464)
Cardiovascular disease (50)
Career advice (701)
Cell therapy (67)
Clinical research (41529)
Collaboration (172)
Compensation (62)
COVID-19 (1068)
Data (480)
Diabetes (84)
Diagnostics (1706)
Drug pricing (90)
Earnings (37919)
Employer resources (73)
Events (47305)
Executive appointments (164)
FDA (7851)
Funding (126)
Gene therapy (81)
GLP-1 (469)
Government (1791)
Healthcare (5844)
Infectious disease (1112)
Inflammatory bowel disease (66)
Interviews (114)
IPO (7275)
Job creations (2428)
Job search strategy (644)
Layoffs (249)
Legal (4072)
Lung cancer (88)
Manufacturing (110)
Medical device (1943)
Medtech (1946)
Mergers & acquisitions (11217)
Metabolic disorders (298)
Neuroscience (700)
NextGen Class of 2024 (2346)
Non-profit (900)
Northern California (555)
Obesity (195)
Opinion (172)
Patents (66)
People (32810)
Pharmaceutical (75)
Phase I (12923)
Phase II (17577)
Phase III (14166)
Pipeline (139)
Podcasts (53)
Policy (65)
Postmarket research (1609)
Preclinical (4536)
Radiopharmaceuticals (154)
Rare diseases (119)
Real estate (3164)
Regulatory (12078)
Research institute (815)
Resumes & cover letters (138)
Southern California (518)
Startups (2004)
United States (5252)
Vaccines (204)
Weight loss (176)
Date
Today (90)
Last 7 days (392)
Last 30 days (1432)
Last 365 days (17967)
2024 (15248)
2023 (19635)
2022 (25865)
2021 (26639)
2020 (24871)
2019 (20058)
2018 (15587)
2017 (17254)
2016 (16202)
2015 (18801)
2014 (14787)
2013 (12552)
2012 (13482)
2011 (13817)
2010 (12738)
Location
Africa (406)
Arizona (49)
Asia (24381)
Australia (3137)
California (1250)
Canada (678)
China (123)
Colorado (50)
Connecticut (50)
Europe (50291)
Florida (166)
Illinois (125)
Indiana (107)
Kansas (55)
Maryland (202)
Massachusetts (1075)
Minnesota (76)
New Jersey (498)
New York (379)
North Carolina (338)
Northern California (555)
Ohio (60)
Pennsylvania (321)
South America (603)
Southern California (518)
Texas (156)
Washington State (125)
326,323 Results for "fennec pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Fennec Pharmaceuticals Announces Management Change
Fennec Pharmaceuticals Inc., a commercial stage specialty pharmaceutical company, announced that Adrian Haigh has departed from his position as Fennec’s Chief Operating Officer as of June 30, 2024.
July 1, 2024
·
4 min read
Press Releases
Fennec Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024
October 31, 2024
·
1 min read
Bio NC
Fennec Announces Results of Annual Meeting - June 25, 2024
Fennec Pharmaceuticals Inc. announced that the nominees listed in the management proxy circular dated April 29, 2024 for the Annual General Meeting of Shareholders were elected as directors of the Company at the Annual General Meeting of Shareholders held in New York, New York on June 25, 2024.
June 25, 2024
·
1 min read
Press Releases
Fennec Pharmaceuticals Strengthens Executive Leadership Team with Three Key Appointments to Accelerate the Company’s Next Stage of Growth
October 28, 2024
·
11 min read
Business
Fennec Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
Fennec Pharmaceuticals Inc., a specialty pharmaceutical company, reported its financial results for the first quarter ended March 31, 2024, and provided a business update.
May 14, 2024
·
14 min read
Business
Fennec Pharmaceuticals to Report First Quarter 2024 Financial Results on May 14, 2024
Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will release its first quarter 2024 financial results before the opening of the U.S. financial markets on Tuesday, May 14, 2024.
May 7, 2024
·
1 min read
Press Releases
Fennec Pharmaceuticals to Participate in Upcoming September 2024 Investor Conferences
September 5, 2024
·
1 min read
Bio NC
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
Fennec Pharmaceuticals Inc. and Norgine announced an exclusive licensing agreement under which Norgine will commercialize PEDMARQSI® in Europe, Australia and New Zealand.
March 17, 2024
·
7 min read
Business
Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update
Fennec Pharmaceuticals Inc., a specialty pharmaceutical company, reported its financial results for the fiscal year ended December 31, 2023 and provided a business update.
March 21, 2024
·
15 min read
Press Releases
Fennec Pharmaceuticals Appoints Jeffrey S. Hackman as Chief Executive Officer and Director
August 5, 2024
·
3 min read
1 of 32,633
Next
